Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives are to assess the efficacy (as measured by the reduction of the signs and symptoms of RA) and the safety and tolerability of JNJ-39758979 at doses of 10, 30, 100, or 300 mg/d compared with placebo in subjects with active RA despite concomitant methotrexate (MTX) therapy.
Critère d'inclusion
- Rheumatoid Arthritis